Markus Sieger Cyclo Therapeutics, Inc. (CYTH) insider trading activity

Markus Sieger is Director of Cyclo Therapeutics, Inc.. Currently has a direct ownership of 440,260 shares of CYTH, which is worth approximately $299,376. The most recent transaction as insider was on Feb 27, 2025, when has been sold 58,138 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 440K

15.21% 3M change

41.71% 12M change

Total Value Held $299,376

Markus Sieger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 27 2025	BUY Grant, award, or other acquisition	-	58,138 Added 11.66%	440,260 Common Stock
Nov 15 2024	BUY Grant, award, or other acquisition	-	35,022 Added 8.4%	382,122 Common Stock
Aug 16 2024	BUY Grant, award, or other acquisition	-	18,354 Added 5.02%	347,100 Common Stock
Jun 03 2024	BUY Grant, award, or other acquisition	-	18,067 Added 5.21%	328,746 Common Stock
Feb 13 2024	BUY Grant, award, or other acquisition	-	14,004 Added 4.31%	310,679 Common Stock
Nov 28 2023	BUY Grant, award, or other acquisition	-	16,512 Added 5.27%	296,675 Common Stock
Oct 20 2023	BUY Exercise of in-the-money or at-the-money derivatives securities	$42,515 $0.71 p/Share	59,881 Added 17.61%	280,163 Common Stock
Aug 18 2023	BUY Grant, award, or other acquisition	-	16,269 Added 6.88%	220,282 Common Stock
May 17 2023	BUY Grant, award, or other acquisition	-	42,962 Added 17.4%	204,013 Common Stock
Apr 20 2023	BUY Open market or private purchase	$42,515 $0.71 p/Share	59,881 Added 27.1%	161,051 Common Stock
Nov 08 2022	BUY Grant, award, or other acquisition	-	9,496 Added 8.58%	101,170 Common Stock
Aug 02 2022	BUY Grant, award, or other acquisition	-	5,762 Added 5.91%	91,674 Common Stock
May 03 2022	BUY Grant, award, or other acquisition	-	4,223 Added 4.69%	85,912 Common Stock
Mar 29 2022	BUY Open market or private purchase	$27,300 $2.73 p/Share	10,000 Added 10.91%	81,689 Common Stock
Jan 28 2022	BUY Grant, award, or other acquisition	-	4,075 Added 5.38%	71,689 Common Stock
Mar 29 2021	BUY Open market or private purchase	$81,000 $8.1 p/Share	10,000 Added 12.88%	67,614 Common Stock
Jan 26 2021	BUY Open market or private purchase	$14,527 $6.6 p/Share	2,201 Added 3.68%	57,614 Common Stock
Jan 25 2021	BUY Open market or private purchase	$49,134 $6.3 p/Share	7,799 Added 12.34%	55,413 Common Stock
Dec 11 2020	BUY Open market or private purchase	-	15,000 Added 17.1%	72,729 Common Stock

Markus Sieger

Director

Gainesville, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTH shares.

Notify only if

Value

Insider Trading

Get notified when an Cyclo Therapeutics, Inc. insider buys or sells CYTH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cyclo Therapeutics, Inc.

Track Activities on CYTH

Account